Elsevier

Progress in Cardiovascular Diseases

Volume 65, March–April 2021, Pages 84-88
Progress in Cardiovascular Diseases

Dialysis access intervention: Techniques for the interventional cardiologist

https://doi.org/10.1016/j.pcad.2021.02.007Get rights and content

Abstract

Interventional cardiologists who treat malfunctioning hemodialysis accesses play an important role in the life of patients with end-stage kidney disease (ESKD). By collaborating with interventional nephrologists who currently perform the bulk of routine access angiographic procedures, interventional cardiologists can fill an important gap in the care of ESKD patients by performing urgent or emergent procedures that fall outside the schedule of an outpatient interventional nephrology laboratory to ensure that hemodialysis patients will not miss a hemodialysis session or get a temporary catheter. This paper reviews the pathophysiology of dialysis access failure and illustrates the catheter-based approaches used by interventional cardiologists to treat malfunctioning dialysis accesses.

Introduction

Approximately 2 in every 1000 persons in the US have end-stage kidney disease (ESKD), and > 80% of these individuals undergo hemodialysis.1 Functioning arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs) are the lifeline for patients with ESKD. An AVF is surgically created when an artery is directly anastomosed with autogenous vein (Fig. 1).2 An AVG is created when a segment of a prosthetic material like PTFE (polytetrafluoroethylene) connects a native artery with a vein (Fig. 1).

Hemodialysis AVFs and AVGs have limited patency. AVFs generally have longer patencies than AVGs but are not feasible for every patient. Accordingly, the “Fistula First” policy of 20063 has been supplanted by a patient-centered approach that creates an individualized life plan that allows changes in access in response to changing circumstances.4 Common modes of failure for hemodialysis AVFs and AVGs are the early appearance of a stenosis at the inflow arteriovenous anastomosis or the late development of an outflow stenosis in the venous limb. When hemodialysis accesses develop a severe stenosis and slow flow, stasis may lead to thrombosis. In non-thrombosed or thrombosed AVFs and AVGs, catheter-based treatments can promptly restore the usability of the access and have the added advantage over surgical revision of saving venous conduit for future accesses.

Although most AV access interventions are performed in outpatient laboratories by interventional nephrologists, some procedures require the urgent scheduling familiar to interventional cardiologists who treat patients with unstable angina or acute myocardial infarction. Many interventional cardiology groups have more than 20-years' experience performing AV access procedures on demand 7 days a week and have maintained a collegial relationship with interventional nephrologists and clinical nephrologists, who provide all the medical care for ESKD patients and much of the critical care for cardiac patients with or without chronic kidney disease (CKD).

Section snippets

Pathophysiology of access failure

In 2014 there were 120,688 new patients who required hemodialysis in the US, bringing the total number of patients with ESKD undergoing renal replacement therapy (RRT) to 678,383.1 The growing prevalence of ESKD has been attributed to the under-treatment of hypertension and the growing incidence of diabetes and CKD. In 2014 the annual mortality rate for patients on hemodialysis was 16%,1 which reflects an improvement in the mortality rate of 24% that existed in 2002.5 Even though the ESKD

Clinical signs and symptoms of access malfunction

The history may provide clues about the location of an inflow or outflow obstruction. Failure of a new AVF to develop suggests the presence of an inflow stenosis. Increased post-dialysis bleeding suggests the development of an outflow stenosis. The physical examination may reveal the site of access stenosis. A continuous medium-pitched bruit and a prominent thrill along the length of a ballotable access are the hallmarks of a normal access. Booming pulsation and a short high-pitched bruit are

Diagnostic angiography to evaluate access malfunction

A fistulogram is indicated when hemodialysis cannot be successfully carried out or when thrombosis is present or imminent. Physical signs of imminent thrombosis include a softening or disappearance of a bruit or thrill or a change from a continuous medium-pitched bruit to a short high-pitched bruit. Technical signs of imminent thrombosis include repeated difficulty accessing the AVF or AVG, access-needle thrombosis, decreased dialysis efficiency or increased dialysis time, increasing pressure

Non-thrombosed accesses

Catheter-based therapy of malfunctioning non-thrombosed AVFs and AVGs is straightforward. A diagnostic fistulogram is first obtained through a 4 Fr Micropuncture® access set (Cook, Inc) directed toward the inflow if the AVF is hypoplastic or directed toward the outflow if there is suspicion of an outflow stenosis. When a stenosis is identified, angioplasty can be carried out through a 4 Fr sheath using coronary angioplasty balloons or through 4 Fr or 5 Fr sheaths using peripheral monorail

Summary

The life expectancy for patients on hemodialysis is directly related to hemodialysis-access patency. When there is close collaboration between interventional cardiologists and nephrologists, patients with malfunctioning accesses can undergo prompt catheter-based treatments, have successful restoration of flow, and avoid temporary catheters or an interruption in hemodialysis. Additional studies are required to identify treatments that reduce stenosis formation in hemodialysis AVFs and AVGs, to

Disclosures

None.

Declaration of Competing Interest

None.

References (26)

  • US Renal Data System

    USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States

    (2003)
  • G.A. Beathard et al.

    Definitions and end points for interventional studies for arteriovenous dialysis access

    Clin J Am Soc Nephrol

    (2018)
  • J.A. Bittl et al.

    Adaptive remodeling of hypoplastic hemodialysis fistulas salvaged with angioplasty

    Catheter Cardiovasc Interv

    (2009)
  • Cited by (1)

    View full text